Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Other Non-Current Assets (2016 - 2025)

Immucell (ICCC) has disclosed Other Non-Current Assets for 16 consecutive years, with $44345.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Assets rose 53.45% year-over-year to $44345.0, compared with a TTM value of $44345.0 through Sep 2025, up 53.45%, and an annual FY2024 reading of $33368.0, down 42.12% over the prior year.
  • Other Non-Current Assets was $44345.0 for Q3 2025 at Immucell, down from $53619.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $14.0 million in Q4 2022 and bottomed at $800.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $813892.2, with a median of $35523.5 recorded in 2024.
  • The sharpest move saw Other Non-Current Assets skyrocketed 53488.96% in 2022, then crashed 99.59% in 2023.
  • Year by year, Other Non-Current Assets stood at $26115.0 in 2021, then surged by 53488.96% to $14.0 million in 2022, then plummeted by 99.59% to $57655.0 in 2023, then plummeted by 42.12% to $33368.0 in 2024, then surged by 32.9% to $44345.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for ICCC at $44345.0 in Q3 2025, $53619.0 in Q2 2025, and $45417.0 in Q1 2025.